These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10752064)

  • 1. Timing-dependent modulation of insulin mitogenic versus metabolic signalling.
    De Meyts P; Shymko RM
    Novartis Found Symp; 2000; 227():46-57; discussion 57-60. PubMed ID: 10752064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding.
    Shymko RM; Dumont E; De Meyts P; Dumont JE
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):675-83. PubMed ID: 10215607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the time factor in signaling specificity: application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases.
    De Meyts P; Christoffersen CT; Ursø B; Wallach B; Grønskov K; Yakushiji F; Shymko RM
    Metabolism; 1995 Oct; 44(10 Suppl 4):2-11. PubMed ID: 7476307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Logical analysis of timing-dependent receptor signalling specificity: application to the insulin receptor metabolic and mitogenic signalling pathways.
    Shymko RM; De Meyts P; Thomas R
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):463-9. PubMed ID: 9291119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review on the in vitro interaction of insulin glargine with the insulin/insulin-like growth factor system: potential implications for metabolic and mitogenic activities.
    Ciaraldi TP; Sasaoka T
    Horm Metab Res; 2011 Jan; 43(1):1-10. PubMed ID: 20938889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin signalling: metabolic pathways and mechanisms for specificity.
    Nystrom FH; Quon MJ
    Cell Signal; 1999 Aug; 11(8):563-74. PubMed ID: 10433517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor.
    Ish-Shalom D; Christoffersen CT; Vorwerk P; Sacerdoti-Sierra N; Shymko RM; Naor D; De Meyts P
    Diabetologia; 1997 Jul; 40 Suppl 2():S25-31. PubMed ID: 9248698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IGF system.
    Annunziata M; Granata R; Ghigo E
    Acta Diabetol; 2011 Mar; 48(1):1-9. PubMed ID: 21042815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRS-4 mediated mitogenic signalling by insulin and growth hormone in LB cells, a murine T-cell lymphoma devoid of IGF-I receptors.
    Ursø B; Ilondo MM; Holst PA; Christoffersen CT; Ouwens M; Giorgetti S; Van Obberghen E; Naor D; Tornqvist H; De Meyts P
    Cell Signal; 2003 Apr; 15(4):385-94. PubMed ID: 12618213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor.
    Milazzo G; Sciacca L; Papa V; Goldfine ID; Vigneri R
    Mol Carcinog; 1997 Jan; 18(1):19-25. PubMed ID: 9022809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
    Chen H; Yan GC; Gishizky ML
    Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3.
    Martin JL; Baxter RC
    Growth Factors; 2011 Dec; 29(6):235-44. PubMed ID: 21895551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
    Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
    Valverde AM; Teruel T; Lorenzo M; Benito M
    Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-1 activation of extracellular signal-related kinase-1 and -2 in growth hormone-secreting cells.
    Webster J; Prager D; Melmed S
    Mol Endocrinol; 1994 May; 8(5):539-44. PubMed ID: 8058064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and IGF-1 receptor trafficking and signalling.
    Foti M; Moukil MA; Dudognon P; Carpentier JL
    Novartis Found Symp; 2004; 262():125-41; discussion 141-7, 265-8. PubMed ID: 15562826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
    Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes.
    Le Roith D
    Diabetes Metab Res Rev; 2007 Nov; 23(8):593-9. PubMed ID: 17922476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.